Department of Nuclear Medicine
Tel Aviv, 64239, Israel
NCT Number: NCT00270803
This study investigates the effects of 17mg and 13mg Delta THC on orientation and motor coordination and brain metabolic activity in regular users of marijuana. Subjects were tested twice, after smoking cigarettes with marijuana and after smoking cigarettes without marijuana.On both occasions they performed on a virtual reality maze task. They were afterwards scanned in Positron Emission Tomography (PET) with Fluoro-deoxy-glucose (FDG).
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
Tel Aviv, 64239, Israel
This study investigates the effects of 17mg and 13mg Delta THC on orientation and motor coordination and brain metabolic activity in regular users of marijuana. Subjects were tested twice, after smoking cigarettes with marijuana and after smoking cigarettes without marijuana. On both occasions they performed on a virtual reality maze task. They were afterwards scanned in Positron Emission Tomography (PET) with Fluoro-deoxy-glucose (FDG). 12 subjects were tested so far on both conditions.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral THC 13mg and 17mg smoked in low nicotine cigarettes
Other names: Marijuana, cannabis
Time frame: 30-40 minutes
Time frame: 40 minutes
Time frame: 10 minutes
Tel-Aviv Sourasky Medical Center
Other Gov
The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04965012
Behavior, Chemically-Induced Disorders
Winnipeg, Manitoba, Canada
View Trial DetailsNCT02955329
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT02579421
Chemically-Induced Disorders, Marijuana Abuse
Minneapolis, Minnesota, United States
View Trial DetailsNCT00480441
Behavior, Behavior, Addictive
Philadelphia, Pennsylvania, United States
View Trial Details